2023 - Research.com Medicine in Taiwan Leader Award
2022 - Research.com Medicine in Taiwan Leader Award
2011 - Fellow, The World Academy of Sciences
His primary scientific interests are in Hepatitis B virus, Hepatocellular carcinoma, Immunology, Internal medicine and Virology. His biological study spans a wide range of topics, including Hepatitis B, Viral load and Genotype. Pei-Jer Chen works mostly in the field of Hepatocellular carcinoma, limiting it down to topics relating to Carcinoma and, in certain cases, Prospective cohort study, as a part of the same area of interest.
Immunology connects with themes related to Liver disease in his study. His work deals with themes such as Gastroenterology, Ribavirin, Surgery and Oncology, which intersect with Internal medicine. In his study, Molecular biology is strongly linked to Plasmid, which falls under the umbrella field of Virology.
Pei-Jer Chen mostly deals with Virology, Hepatitis B virus, Internal medicine, Immunology and Hepatocellular carcinoma. His Hepatitis B virus study frequently draws connections to other fields, such as Hepatitis B. The concepts of his Hepatitis B study are interwoven with issues in Viral hepatitis and Liver disease.
Pei-Jer Chen combines subjects such as Gastroenterology, Ribavirin and Oncology with his study of Internal medicine. His research on Immunology often connects related areas such as Genotype. His Hepatocellular carcinoma study combines topics in areas such as Cirrhosis and Pathology.
Pei-Jer Chen mainly focuses on Internal medicine, Hepatitis B virus, Gastroenterology, Hepatocellular carcinoma and Virology. His Internal medicine research incorporates themes from Ribavirin and Hepatitis C virus. His work investigates the relationship between Hepatitis C virus and topics such as Coinfection that intersect with problems in LEDIPASVIR/SOFOSBUVIR.
His Hepatitis B virus study is related to the wider topic of Immunology. His Gastroenterology research includes themes of Interferon, HBeAg, Viral load and Confidence interval. Pei-Jer Chen has included themes like Viral hepatitis, Hepatitis C and Oncology in his Hepatocellular carcinoma study.
His primary areas of investigation include Internal medicine, Hepatitis B virus, Hepatitis B, Gastroenterology and Virology. Pei-Jer Chen is interested in Hepatocellular carcinoma, which is a field of Internal medicine. His Hepatitis B virus research is classified as research in Immunology.
The Hepatitis B study which covers Chronic hepatitis that intersects with Curing, Dna viral and Hepatitis D. The various areas that he examines in his Gastroenterology study include Risk factor, Viral load and Hazard ratio. His study on cccDNA, Dasabuvir and Viremia is often connected to CCL5 as part of broader study in Virology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.
S. K. Sarin;M. Kumar;G. K. Lau;Z. Abbas.
Hepatology International (2016)
Hepatitis B e antigen and the risk of hepatocellular carcinoma.
Hwai I. Yang;Sheng Nan Lu;Yun Fan Liaw;San Lin You.
The New England Journal of Medicine (2002)
Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B
Jia-Horng Kao;Pei-Jer Chen;Ming-Yang Lai;§ Ding-Shinn Chen‡.
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Masao Omata;Ann Lii Cheng;Norihiro Kokudo;Masatoshi Kudo.
Hepatology International (2017)
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.
Masao Omata;Laurentius A. Lesmana;Ryosuke Tateishi;Pei Jer Chen.
Hepatology International (2010)
Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
Ming-Whei Yu;Shiou-Hwei Yeh;Pei-Jer Chen;Yun-Fan Liaw.
Journal of the National Cancer Institute (2005)
Hepatitis B genotypes and the response to interferon therapy.
Jia-Horng Kao;Nan-Hui Wu;Pei-Jer Chen;Ming-Yang Lai.
Journal of Hepatology (2000)
Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma
Hwai I. Yang;Shiou Hwei Yeh;Pei Jer Chen;Pei Jer Chen;Uchenna H. Iloeje.
Journal of the National Cancer Institute (2008)
Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study
Joong Won Park;Minshan Chen;Massimo Colombo;Lewis Rowland Roberts.
Liver International (2015)
Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.
Jia–Horng Kao;Pei–Jer Chen;Ming–Yang Lai;Ding–Shinn Chen.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: